<turbo-stream action="append" target="news"><template>  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Zimmer-Biomet-Holdings-Inc-US98956P1021">Zimmer Biomet Holdings, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">PRNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor etwa 2 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.prnewswire.com/news-releases/zimmer-biomet-announces-first-quarter-2026-financial-results-302754967.html">Zimmer Biomet Announces First Quarter 2026 Financial Results</a>
    </div>

      <div class="me-0 me-md-5">
        First quarter net sales of $2.087 billion increased 9.3% on a reported basis, 6.8% on a constant currency1 basis and 2.9% on an organic constant currency1 basis First quarter diluted earnings per share were $1.22, an increase of 34.1%; adjusted1 diluted earnings per share were $2.09, an increase of 15.5% Company updates full-year 2026 financial guidance WARSAW, Ind., April 28, 2026 /PRNewswire/...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Zimmer-Biomet-Holdings-Inc-US98956P1021">Zimmer Biomet Holdings, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">PRNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor etwa 2 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.prnewswire.com/news-releases/zimmer-biomet-announces-chief-financial-officer-transition-302754861.html">Zimmer Biomet Announces Chief Financial Officer Transition</a>
    </div>

      <div class="me-0 me-md-5">
        Suketu Upadhyay to Depart; Paul Stellato Named Interim CFO WARSAW, Ind., April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced Suketu Upadhyay, Chief Financial Officer and Executive Vice President, Finance, Operations and Supply Chain, will depart the company effective April 28 for a new professional opportunity.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Zimmer-Biomet-Holdings-Inc-US98956P1021">Zimmer Biomet Holdings, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">PRNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 3 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.prnewswire.com/news-releases/zimmer-biomet-announces-webcast-and-conference-call-of-first-quarter-2026-financial-results-302737137.html">Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results</a>
    </div>

      <div class="me-0 me-md-5">
        WARSAW, Ind., April 9, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its first quarter earnings conference call will be webcast on Tuesday, April 28, 2026, at 8:30 a.m.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Zimmer-Biomet-Holdings-Inc-US98956P1021">Zimmer Biomet Holdings, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">PRNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 3 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.prnewswire.com/news-releases/zimmer-biomet-appoints-dr-jonathan-m-vigdorchik-as-chief-science-technology-and-medical-affairs-officer-302735027.html">Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer</a>
    </div>

      <div class="me-0 me-md-5">
        Experienced orthopedic surgeon from the Hospital for Special Surgery, innovator and former Chief Medical Technology Advisor joins company in an elevated capacity WARSAW, Ind., April 7, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Jonathan M.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Zimmer-Biomet-Holdings-Inc-US98956P1021">Zimmer Biomet Holdings, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">AD HOC NEWS</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 3 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.ad-hoc-news.de/boerse/news/ueberblick/zimmer-biomet-aktie-starkes-wachstum-im-orthopaedie-segment-treibt-kurs/68957797">Die Zimmer Biomet Aktie (ISIN: US98956P1021) zeigt robustes Momentum durch positive Quartalszahlen und steigende Nachfrage nach Hüft- und Knieimplantaten. Investoren im DACH-Raum profitieren von der stabilen Position im Medizintechnik-Markt. Hier die Analyse der aktuellen Entwicklungen.</a>
    </div>

      <div class="me-0 me-md-5">
        Zimmer Biomet Aktie: Starkes Wachstum im Orthopädie-Segment treibt Kurs an NYSE
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Zimmer-Biomet-Holdings-Inc-US98956P1021">Zimmer Biomet Holdings, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">AD HOC NEWS</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 3 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.ad-hoc-news.de/boerse/news/ueberblick/zimmer-biomet-holdings-aktie-stabiles-wachstum-im-medizintech-sektor/68717893">Die Zimmer Biomet Holdings Aktie (ISIN: US98956P1021) zeigt auf der AMEX eine solide Performance mit einem Kurs um 93 USD. Investoren achten auf Innovationen in Orthopädie und Robotik. Für DACH-Anleger relevant durch starke Europa-Präsenz und Dividendenstabilität.</a>
    </div>

      <div class="me-0 me-md-5">
        Zimmer Biomet Holdings Aktie: Stabiles Wachstum im Medizintech-Sektor trotz Marktschwankungen
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Zimmer-Biomet-Holdings-Inc-US98956P1021">Zimmer Biomet Holdings, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">AD HOC NEWS</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 4 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.ad-hoc-news.de/boerse/news/ueberblick/zimmer-biomet-aktie-was-dach-anleger-jetzt-zur-us98956p1021-wissen/68659470">Zimmer Biomet bleibt einer der weltweit wichtigsten Anbieter von orthopädischen Implantaten, steht aber nach gemischten Quartalszahlen und einem verhaltenen Ausblick unter Beobachtung. Für Anleger im deutschsprachigen Raum stellt sich die Frage, ob die Aktie nach der jüngsten Konsolidierung eher Chance oder Risiko ist. Dieser Beitrag ordnet die aktuellen Zahlen, die Bewertung und die Perspektiven für die nächsten 12 Monate ein.</a>
    </div>

      <div class="me-0 me-md-5">
        Zimmer Biomet Aktie: Was DACH-Anleger jetzt zur US98956P1021 wissen sollten
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Zimmer-Biomet-Holdings-Inc-US98956P1021">Zimmer Biomet Holdings, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">GlobeNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 4 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.globenewswire.com/news-release/2026/03/06/3251062/0/en/Zimmer-Biomet-Holdings-Inc-Investigated-by-the-Portnoy-Law-Firm.html">Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm</a>
    </div>

      <div class="me-0 me-md-5">
        LOS ANGELES, March 06, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Zimmer Biomet Holdings, Inc., (“Zimmer&quot; or the &quot;Company&quot;) (NYSE:ZBH) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

</template></turbo-stream><turbo-stream action="replace" target="link"><template><div id="link">
    <a class="btn btn-outline-primary btn--small" data-turbo-stream="" href="/news/Zimmer-Biomet-Holdings-Inc-US98956P1021/load_more?page=3">
      Mehr Neuigkeiten anzeigen
      <i class="fa fa-arrow-down fa-fw"></i>
</a></div>
</template></turbo-stream>